A loop system exists between hypothalamic neuropeptide Y (NPY) and peripheral adipose tissue leptin to maintain normal body homeostasis. When hypothalamic NPY levels are increased by fasting or by intracerebroventricular (i.c.v.) infusion, food intake and body weight increase. NPY has genuine hormono-metabolic effects. It increases insulin and corticosterone secretion relative to controls. These hormonal changes, acting singly or combined, favor adipose tissue lipogenic activity, while producing muscle insulin resistance. They also promote leptin release from adipose tissue. When infused i.c.v. to normal rats to mimick its central effects, leptin decreases NPY levels, thus food intake and body weight. Leptin i.c.v. has also genuine hormono-metabolic effects. It decreases insulinemia and adipose tissue storage ability, enhancing glucose disposal. Leptin increases the expression of uncoupling proteins (UCP-1, -2, -3) and thus energy dissipation. Leptin-induced changes favor oxidation at the expense of storage. Circadian¯uctuations of NPY and leptin levels maintain normal body homeostasis. In animal obesity, defective hypothalamic leptin receptor activation prevent leptin from acting, with resulting obesity, insulin and leptin resistance.
Introduction
To maintain a normal body weight homeostasis, the partitioning of energy from incoming nutrients is tightly regulated. For such regulation, loop systems linking the central nervous system, the hypothalamus in particular, to peripheral organs have been described. The present summary will focus on the role of one hypothalamic neuropeptide, neuropeptide Y or NPY, and one peripheral hormone, adipose tissue leptin, and their respective roles on energy partitioning. To brie¯y summarize, it may be stated that NPY and leptin not only have functional inter-relationships, with one acting on the other, but they have genuine hormono-metabolic effects that lead to ultimate, opposite actions on energy partitioning.
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Results and discussion
When an animal is hungry, increased synthesis of NPY is observed within the hypothalamic arcuate nucleus. To determine the consequences of such an increase in central NPY levels, we adopted the following experimental design: normal rats were infused for 7 days with NPY, or its vehicle, into a lateral cerebral ventricle, ie intracerebroventricularly (i.c.v.). During this experimental period, food intake, body weight, as well as plasma insulin and corticosterone levels were measured daily. Additionally, metabolic parameters, such as the insulin-stimulated glucose uptake by white adipose tissue and muscles, were determined at the end of the 7 day experimental period using euglycemic ± hyperinsulinemic clamps associated with the labeled 2-deoxy-glucose technique. 3 ± 5 When considering food intake and body weight, it was evident that NPY-infused rats had a markedly greater food intake and body weight gain, these parameters being about 3-fold higher than those of controls. As both plasma insulin and corticosterone levels increase during a meal, we decided to measure these hormonal parameters, both in NPY-and in vehicle-infused animals. It was observed that basal insulinemia was more than doubled in the i.c.v. NPYinfused rats compared with controls. The increase in the insulin response of the NPY-infused rats was present one day after NPY infusion, and it remained elevated during the whole experimental period. 3 ± 5 Another interesting ®nding related to basal insulinemia was that the hyperinsulinemia resulting from NPY infusion was completely prevented when central NPY infusion was carried out in vagotomized rats. This clearly showed the parasympathetic mediation of i.c.v NPY-induced hyperinsulinemia. 6 NPY-infused rats had marked increases in corticosteronemia compared to vehicle-infused controls. This increase was of early occurrence (ie within one day) and was maintained during the whole experimental period. 3, 5 In addition, NPY-infused animals became more susceptible to stressful situations than controls, as evidenced by much greater plasma ACTH levels in response to a short (2 h) cold exposure test. 6 The metabolic consequences of i.c.v. NPY infusion were studied, in both white adipose tissue and muscle. The insulin-stimulated glucose uptake, as measured in white adipose tissue during euglycemic ± hyperinsulinemic clamps associated with the labeled 2-deoxyglucose technique, was markedly enhanced by i.c.v. NPY infusion. 3 ± 5 This, together with the observed increase in white adipose tissue lipogenic activity, assessed by measurements of both the de novo lipogenesis and the activity of lipoprotein lipase, 3 resulted in increased fat deposition in the i.c.v. NPY-infused group and, with time, in incipient obesity. The situation was completely different when the muscle mass was considered. Indeed, it was observed that compared with vehicle-infused control animals, the insulin-stimulated glucose uptake of various muscle types was markedly decreased in the NPY-infused group, indicating the presence of a state of muscle insulin resistance. 3 ± 6 The effect of i.c.v. infusion of NPY on both adipose tissue ob expression and released leptin was then investigated. It was observed that central NPY administration resulted in a 3-fold increase in ob gene expression compared with controls. 7 In keeping with this observation, plasma leptin levels were markedly elevated in NPY-infused rats when compared with controls. Such increases in both ob gene expression and leptin output are the likely result of the concomitant presence of NPY-induced hyperinsulinemia and hypercorticosteronemia, as these two hormones are known to acutely stimulate leptin production, at least in rodents. 8, 9 The effect of central NPY administration on uncoupling protein 2 (UCP2) expression in adipose tissue was studied and found to be markedly decreased in NPY-infused rats compared with controls. If one considers that UCP2 is one of the mediators of energy dissipation amongst the other uncoupling proteins described so far, one can suggest that central NPY infusion has an inhibitory effect on such a process (manuscript in preparation).
To summarize the effects of i.c.v. NPY infusion in normal rats, it can be stated that NPY: (1) stimulates food intake and body weight gain; (2) increases plasma insulin levels via an activation of the parasympathetic nervous system; (3) promotes an increased activity of the hypothalamo ± pituitary ± adrenal axis with resulting hypercorticosteronemia; (4) has, via the concomitant presence of hyperinsulinemia and hypercorticosteronemia, metabolic consequences on energy partitioning as hyperinsulinemia leads to increased fat deposition and therefore to obesity, while hyperinsulinemia together with hypercorticosteronemia leads to muscle insulin resistance; (5) is responsible, via alterations in plasma insulin and glucocorticoid levels, for the establishment of a state of hyperleptinemia; and (6) is likely to decrease energy dissipation as heat.
If we place these conclusions in a physiological perspective, one can say that when a normal animal is hungry and its hypothalamic NPY levels are spontaneously increasing, the animal will ®rst eat, then store most of the ingested nutrients as fat instead of oxidizing them and, ®nally, leptinemia will increase to bring about satiety and the end of the meal. The metabolic effects elicited by central NPY infusion are mediated by hormonal alterations, as well as by a central activation of the autonomic nervous system, the parasympathetic branch, in particular. 1, 2 Let us now consider data obtained with leptin. Leptin is known as a satiety hormone acting on the long form of its receptor, mainly located within the hypothalamus. 10 ± 12 To investigate whether leptin has hormono-metabolic effects, we adopted the following experimental design: normal rats were infused i.c.v. for 4 days with leptin or its vehicle. 13 During this period, body weight and food intake were measured daily. At the end of the experiment, the plasma levels of some hormones were determined. The insulinstimulated glucose uptake by individual tissues such as white adipose tissue and muscles at the end of euglycemic-hyperinsulinemic clamps associated with the labeled 2-deoxy-glucose technique was also measured.
A ®rst important effect of i.c.v leptin was to decrease NPY content both in its site of synthesis, the arcuate nucleus, and its site of release, the paraventricular hypothalamic nucleus. 14 ± 16 Consequently, central leptin infusion resulted in a marked and sustained decrease in food intake (about 40%), a decrease that was accompanied by a marked decrease in body weight compared with controls. 13 I.c.v. leptin infusion also markedly decreased basal insulinemia, an effect that was due to the decrease in food intake as it could be mimicked by pair-feeding, ie it was also observed in control animals receiving the same amount of food as leptin-infused rats. 13 
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The metabolic consequences of chronic central leptin infusion can be summarized as follows. The insulin-induced glucose utilization of white adipose tissue, and de novo lipogenesis tended to be lower in leptin-infused rats than in controls. However, leptin administration resulted in increased insulin-stimulated total as well as muscle glucose utilization, indicative of a state of increased sensitivity to insulin. 13 Therefore, as for NPY, but in an opposite direction, central leptin infusion was responsible for an alteration of nutrient partitioning. It favored glucose utilization, while inhibiting ultimate storage of lipids in adipose tissue stores. 13 The levels of expression of the different uncoupling proteins, UCP-1, UCP-2 and UCP-3 in brown adipose tissue were then investigated. It was found that, compared with the levels of expression measured in the respective control animals, those of UCP-1, UCP-2 and UCP-3 were increased in brown adipose tissue of leptin-infused rats. The same holds true for the expression of UCP-2 in the liver and in white adipose tissue, as well as for that of UCP-3 in muscles, where all were increased by i.c.v. leptin infusion relative to pair-fed controls. 13 It should be emphasized that the hormono-metabolic effects brought about by i.c.v leptin administration were observed without increases in plasma leptin levels, which could have been due to leakage of the hormone. The leptinemia of leptin-infused rats was in fact lower than that of the controls, a likely consequence of their body weight loss. When leptin was given peripherally instead of i.c.v., leptinemia was elevated more than 50 times, but the same changes in food intake, body weight, insulinemia, metabolic alterations and expressions of uncoupling proteins were observed. 17 This strongly suggested that leptin may have no or little direct effect on peripheral tissues, at least when considering those measured during our studies. It is suggested that the effects of leptin on the periphery may occur via the central activation of sympathetic efferences.
To conclude, the following may be stated: (a) NPY produces a series of processes that include increases in insulinemia and corticosteronemia, with the two together favouring the channeling of substrates into fat depots. In addition, NPY exerts inhibitory effects on energy dissipating mechanisms and on insulin-stimulated glucose utilization by the muscle mass, the latter effect being presumably due to increases in corticosteronemia. All these changes lead to the development of overweight andaor obesity, possibly to type 2 diabetes. (b) The hormono-metabolic changes elicited by central leptin administration are the mirror image of those elicited by NPY, as i.c.v. leptin infusion results in decreases in insulinemia as well as in fat storage, while it favors muscle glucose utilization and presumably stimulates energy dissipation. In contrast to central NPY infusion, the central administration of leptin leads to decreased body weight and more particularly to body fat loss. 1, 2 Finally, NPY and leptin belong to a feed-back loop system that links the hypothalamus and the periphery. Thus, on the one hand, central NPY stimulates leptin secretion from adipose tissue and, on the other hand, leptin inhibits the NPY effects by decreasing hypothalamic NPY content. An adequate function of this feedback loop is essential for the maintenance of a normal body weight homeostasis, and overweight or obesity occurs when this loop is dysfunctional. Most of the present examples of such dysfunctions are provided by the existence of hypothalamic leptin receptor mutations, impaired leptin signaling systems, impaired access of leptin into the central nervous system. In such situations, hypothalamic NPY levels remain high, bringing about the hormono-metabolic changes summarized above, thus leading to obesity with resulting hyperleptinemia and leptin resistance. 1, 2 
